
Drug Development Pharma - January 30, 2015
ILUVIEN Approved in Finland
The Finnish Medicines Agency and the Ministry of Health in Luxembourg have granted marketing authorization for Alimera Sciences, Inc.’s drug ILUVIEN®, used in the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered unresponsive to available therapies. ILUVIEN is now approved for marketing in Austria, Belgium, Denmark, France, Germany, Ireland, Italy, the […]

Companies - January 20, 2015
Cytomed to Make Flu Drug in Finland
Russian-owned company Cytomed, which has a pharmaceutical plant near Lappeenranta in eastern Finland, won approval from the Finnish Medicines Agency to start production of its influenza medicine Cytovir-3. Cytomed’s Finnish pharmaceutical plant was built in 2012 and is focused on producing drugs for the Russian market. Julia Volkov, Cytomed’s CEO in Finland, said exports to […]